Evidence map›Paper›PMID 31101438›Full record

ReviewNeuroscience and biobehavioral reviews2020

Abuse potential and toxicity of the synthetic cathinones (i.e., "Bath salts").

Anthony L Riley, Katharine H Nelson, Peter To, Raul López-Arnau, Peng Xu, Dan Wang, Youmei Wang, Hao-Wei Shen, Donald M Kuhn, Mariana Angoa-Perez and 3 more

Open access · greenAbstract readReview
In one paragraph

Review in Neuroscience and biobehavioral reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Anthony L RileyPsychopharmacology Laboratory, Center for Behavioral Neuroscience, American University, 4400 Massachusetts Ave, NW, Washington, DC, USA. Electronic address: alriley@american.edu.
Katharine H NelsonPsychopharmacology Laboratory, Center for Behavioral Neuroscience, American University, 4400 Massachusetts Ave, NW, Washington, DC, USA.
Peter ToPsychopharmacology Laboratory, Center for Behavioral Neuroscience, American University, 4400 Massachusetts Ave, NW, Washington, DC, USA.
Raul López-ArnauPsychopharmacology Laboratory, Center for Behavioral Neuroscience, American University, 4400 Massachusetts Ave, NW, Washington, DC, USA; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacology Section and Institute of Biomedicine (IBUB), Faculty of Pharmacy and Food Science, University of Barcelona, Barcelona, Spain.
Peng XuDrug Intelligence and Forensic Center, Ministry of Public Security, Beijing, PR China.
Dan WangDrug Intelligence and Forensic Center, Ministry of Public Security, Beijing, PR China.
Youmei WangDrug Intelligence and Forensic Center, Ministry of Public Security, Beijing, PR China.
Hao-Wei ShenDepartment of Pharmacology, Medical School of Ningbo University, Ningbo, Zhejiang Province, China.
Donald M KuhnResearch & Development Service, John D. Dingell VA Medical Center, Detroit, Michigan, USA; Department of Psychiatry & Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA.
Mariana Angoa-PerezResearch & Development Service, John D. Dingell VA Medical Center, Detroit, Michigan, USA; Department of Psychiatry & Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA.
John H AnnekenResearch & Development Service, John D. Dingell VA Medical Center, Detroit, Michigan, USA; Department of Psychiatry & Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA.
Dawn MuskiewiczDepartment of Pharmacology & Experimental Therapeutics, College of Pharmacology and Pharmacological Science, University of Toledo, OH, USA.
F Scott HallDepartment of Pharmacology & Experimental Therapeutics, College of Pharmacology and Pharmacological Science, University of Toledo, OH, USA.
American University · USMinistry of Public Security of the People's Republic of China · CNWayne State University · USUniversity of Toledo · USNingbo University · CN

Funding

RR&D Research Career Scientist Award ApplicationIK6RX002419 · VA · JOHN D DINGELL VA MEDICAL CENTER · PI KUHN, DONALD M · 2017 to 2023
–
RRD VA IK6 RX002419
6 · The paper itself

Abstract

The synthetic cathinones are derived from the naturally occurring drug cathinone found in the khat plant (Catha edulis) and have chemical structures and neurochemical consequences similar to other psychostimulants. This class of new psychoactive substances (NPS) also has potential for use and abuse coupled with a range of possible adverse effects including neurotoxicity and lethality. This review provides a general background of the synthetic cathinones in terms of the motivation for and patterns and demographics of their use as well as the behavioral and physiological effects that led to their spread as abused substances and consequent regulatory control. This background is followed by a review focusing on their rewarding and aversive effects as assessed in various pre-clinical animal models and the contribution of these effects to their self-administration (implicating their use and abuse potential). The review closes with an overview of the consequences of synthetic cathinone use and abuse in terms of their potential to produce neurotoxicity and lethality. These characterizations are discussed in the context of other classical psychostimulants.

Indexed as

AlkaloidsCentral Nervous System StimulantsAnimalsHumansMethamphetaminePsychotropic DrugsSelf AdministrationSubstance-Related DisordersAlkaloidscathinoneCentral Nervous System StimulantsMethamphetaminePsychotropic Drugs“Bath salts”Drug abuseLethalityNeurotoxicityNew psychoactive substances (NPS)Synthetic cathinones

Identifiers

PMID31101438
PMCPMC8617600
OpenAlexW2946700363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.